Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denmark
Biotech
Genmab's growth plan entails partnering less, owning more: CEO
Genmab CEO Jan van de Winkel says he and investors are aligned that M&A is a logical next step for growth.
Max Bayer
Mar 14, 2024 9:40am
Novo Nordisk invests $749M to boost API manufacturing for trials
Nov 22, 2022 9:25am
Leo Pharma's new CEO comes from failed meme stock Orphazyme
Jan 31, 2022 12:09pm
Eir raises $138M fund to fill gap in Nordic life science scene
Dec 9, 2021 3:00am
Coloplast picks up voice box maker Atos Medical in €2B deal
Nov 9, 2021 4:10pm
Bavarian Nordic gets government support for COVID booster trial
Sep 24, 2021 8:20am
